Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

OBJECTIVES This study aims to define the diagnostic utility of flow cytometric features of T cells in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). METHODS Cases were retrospectively identified based on diagnosis with NLPHL (n = 30 samples), classic Hodgkin lymphoma (CHL; n = 33), and reactive lymphoid hyperplasia (RLH; n = 43). Pathology slides were reviewed. Flow cytometry list mode data were reanalyzed. RESULTS The mean proportion of CD4 + CD8 + T cells (8.4%) in cases of NLPHL was significantly higher than seen in CHL (1.0%) or RLH (0.6%). Of the T cells, 28.4% were CD57 + in NLPHL, significantly higher (P < .05) than in CHL (3.2%) or RLH (3.2%). Based on receiver operating characteristic curve analysis, when using a cutoff of 3.0% of CD4 + CD8 + T cells, the diagnostic sensitivity for NLPHL is 83.3% with a specificity of 97.4%. The diagnostic sensitivity was 96.7% with a specificity of 98.7% when using a cutoff of 12% for CD57 + T cells. CONCLUSIONS Increased portions of CD57 + T cells and CD4 + CD8 + T cells are highly suggestive of the possibility of NLPHL. In addition, NLPHL diagnosis appears unlikely if neither CD57 + T cells nor CD4 + CD8 + T cells are increased. Future prospective studies including cases of progressive transformation of germinal center and T-cell/histiocyte-rich large B-cell lymphoma will further define the utility of flow cytometry of T cells in NLPHL.

[1]  Armanda D. Tatsas,et al.  Nodular lymphocyte‐predominant Hodgkin lymphoma , 2012, Cancer cytopathology.

[2]  B. Wood,et al.  Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting. , 2012, Methods.

[3]  A. Carbone,et al.  "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease. , 2012, Human pathology.

[4]  A. Wotherspoon,et al.  The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management , 2012, Leukemia & lymphoma.

[5]  S. Pileri,et al.  Pathobiology of Hodgkin Lymphoma , 2010, Advances in hematology.

[6]  B. Wood,et al.  Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications , 2010, Advances in hematology.

[7]  R. Advani,et al.  The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma , 2009, Current opinion in oncology.

[8]  A. LaCasce,et al.  Nodular lymphocyte-predominant Hodgkin lymphoma , 2018, Atlas of Genetics and Cytogenetics in Oncology and Haematology.

[9]  E. Jaffe,et al.  Histopathology of Hodgkin’s Lymphoma , 2009, Cancer journal.

[10]  N. Harris,et al.  A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. , 2006, American journal of clinical pathology.

[11]  A. van den Berg,et al.  Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts , 2006, The Journal of pathology.

[12]  M. Kraus,et al.  Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis. , 2000, The American journal of surgical pathology.

[13]  H. Ioniță,et al.  B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[14]  R. Küppers Molecular biology of Hodgkin's lymphoma. , 2002, Advances in cancer research.